Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hemostatic Agent Public Health Notification Sparked By MedSun

This article was originally published in The Gray Sheet

Executive Summary

FDA's April public health notification on absorbable hemostatic agents is the first of its kind to stem from a MedSun report

You may also be interested in...

Expanded MedSun Surveillance Network Highlighted By FDA; Funding Planned

FDA intends to allocate $34 mil. to its Medical Product Surveillance Network (MedSun) in FY 2006, with the goal of recruiting 350 facilities into the program

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts